SGCG and connective tissue disorder: In our study, abnormal bone mineral density was the most commonly reported adverse event among musculoskeletal and connective tissue disorders, followed by three others: increased blood parathyroid hormone, decreased N-terminal prepeptide of serum type I procollagen, and increased ant tartaric acid phosphatase.